HCA financials
HCA Healthcare, Inc. · end-of-day data as of Oct 16, 2026
HCA Healthcare, Inc.
$458.84+20.3%
Hold · 27 analystsPT $468.39 +2.1%
HCA reported revenue of $20.23B for the quarter ended Jun 30, 2026 (Q2 FY2026), up 8.7% from a year earlier. It posted diluted EPS of $7.62, free cash flow of $1.1B and a net margin of 8.4%.
Valuation
- P/E15.4x
- P/E vs own-1.3%
- P/E vs sector-45.4%
- FCF yield+6.0%
- Market cap$99.34B
Quarterly results
Q2 FY2026: Revenue +8.7% year over year, free cash flow 5.5% of revenue, operating margin 15.2%.
RevenueFree cash flow
| Q2 FY2026 | Jun 30, 2026 | $20.23B | 7.62 | $1.1B | 15.2% | 15.2% | 8.4% |
| Q1 FY2026 | Mar 31, 2026 | $19.11B | 7.15 | $895M | 15.0% | 15.0% | 8.5% |
| Q4 FY2025 | Dec 31, 2025 | $19.51B | 8.14 | $870M | 41.9% | 16.3% | 9.6% |
| Q3 FY2025 | Sep 30, 2025 | $19.16B | 6.96 | $3.13B | 41.8% | 15.5% | 8.6% |
| Q2 FY2025 | Jun 30, 2025 | $18.61B | 6.83 | $3.03B | 41.0% | 15.9% | 8.9% |
| Q1 FY2025 | Mar 31, 2025 | $18.32B | 6.45 | $660M | 41.3% | 15.6% | 8.8% |
| Q4 FY2024 | Dec 31, 2024 | $18.29B | 5.63 | $1.27B | 41.4% | 15.6% | 7.9% |
| Q3 FY2024 | Sep 30, 2024 | $17.49B | 4.89 | $2.32B | 39.9% | 13.8% | 7.3% |
| Q2 FY2024 | Jun 30, 2024 | $17.49B | 5.53 | $690M | 41.0% | 15.6% | 8.4% |
| Q1 FY2024 | Mar 31, 2024 | $17.34B | 5.94 | $1.35B | 84.6% | 14.8% | 9.2% |
| Q4 FY2023 | Dec 31, 2023 | $17.3B | 5.93 | $1.51B | 85.1% | 16.2% | 9.3% |
| Q3 FY2023 | Sep 30, 2023 | $16.21B | 3.89 | $1.33B | 85.1% | 0.0% | 6.7% |